Grants & Projects per year
Fingerprint
Dive into the research topics where Hilliard Kutscher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants & Projects
- 2 Finished
-
Immunotherapeutic nanoparticles: Implications for the treatment of tuberculosis and HIV
Reynolds, J. (PI) & Kutscher, H. (CoI)
National Institute of Allergy & Infectious Disease
08/2/23 → 07/31/25
Project: Research
-
UR Center for AIDS Research-Pharmacokinetics and Immunodynamics of Multi-Model Nanoparticles for TB
Kutscher, H. (PI), Morse, E. (CoI) & Prasad, P. (CoI)
National Institute of Allergy & Infectious Disease
08/1/14 → 04/30/17
Project: Research
-
Mesoscopic Fluorescence Imaging of Light Triggered Chemotherapeutic Release in a Cancer Spheroid Model
Kluiszo, E., Ahmmed, R., Aliu, B., Aygun-Sunar, S., Belcastro, L., Willadsen, M., Kutscher, H. L., Lovell, J. F. & Sunar, U., Mar 5 2026, Molecular-Guided Surgery: Molecules, Devices, and Applications XII. Gibbs, S. L. & Tichauer, K. M. (eds.). SPIE, 1383208. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; vol. 13832).Stony Brook University, University at Buffalo
Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review
-
Mesoscopic Fluorescence Imaging of Light-Triggered Chemotherapeutic Release in Cancer Spheroid Models
Kluiszo, E., Ahmmed, R., Aliu, B., Aygun-Sunar, S., Willadsen, M., Kutscher, H. L., Lovell, J. F. & Sunar, U., Apr 2026, In: Pharmaceutics. 18, 4, 495.Stony Brook University, University at Buffalo
Research output: Contribution to journal › Article › peer-review
Open Access -
Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine Development
Sia, Z. R., Huang, W. C., Willadsen, M., Kutscher, H. L., Lovell, J. F. & Davidson, B. A., Apr 5 2026, In: Bio-protocol. 16, 7, e5662.Research output: Contribution to journal › Article › peer-review
Open Access -
Repeated pulmonary dosing of β-glucan-chitosan-PLGA nanoparticles controls Mycobacterium tuberculosis in mice
Kutscher, H. L., Tamblin, M., Smith, E., Shah, A., Kenney, P. O. & Reynolds, J. L., Feb 2026, In: Antimicrobial Agents and Chemotherapy. 70, 2Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of Mycobacterium tuberculosis in BALB/c mice
Kutscher, H. L., Tamblin, M., Kenney, P. & Reynolds, J. L., Jun 2026, In: Antimicrobial Agents and Chemotherapy. 70, 6, e00281-26.Research output: Contribution to journal › Article › peer-review
Open Access